Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients (Q41635015)

5 October 2017

title

Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients (English)

1 reference

5 October 2017

3

Stergiou G

1 reference

Antonella d'Arminio Monforte

5 October 2017

2

object named as

Monforte AD

1 reference

5 October 2017

9

Lundgren JD

1 reference

5 October 2017

Balslev U

1

1 reference

5 October 2017

Antunes F

4

1 reference

5 October 2017

Mulcahy F

5

1 reference

5 October 2017

Pehrson PO

6

1 reference

5 October 2017

Phillips A

7

1 reference

5 October 2017

Pedersen C

8

1 reference

5 October 2017

publication date

1 January 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

29

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

337-343

1 reference

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

The progression of HIV disease in a haemophilic cohort followed for 12 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Survival trends for patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Zidovudine and the natural history of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Survival patterns of the first 500 patients with AIDS in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Prognostic classification for AIDS patients in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549709011827

10.3109/00365549709011827

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference